Nathanael S Dayes

HIV-1 Viral protein-r (Vpr) protects against lethal superantigen challenge while maintaining homeostatic T cell levels in vivo.

D. Weiner, P. Buckley, K. Muthumani, 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

Adenovirus encoding HIV-1 Vpr activates caspase 9 and induces apoptotic cell death in both p53 positive and negative human tumor cell lines

D. Weiner, S. Kudchodkar, H. Maguire, 2002, Oncogene.

HIV-1 viral protein R compromises cellular immune function in vivo.

J. Kim, D. Weiner, L. Montaner, 2002, International immunology.

HIV-1 Vpr inhibits the maturation and activation of macrophages and dendritic cells in vitro.

D. Weiner, K. Muthumani, K. Thieu, 2004, International immunology.

Suppression of HIV-1 viral replication and cellular pathogenesis by a novel p38/JNK kinase inhibitor

D. Weiner, J. Siekierka, K. Muthumani, 2004, AIDS.

HIV-1 Vpr Induces Apoptosis through Caspase 9 in T Cells and Peripheral Blood Mononuclear Cells*

D. Green, D. Weiner, K. Muthumani, 2002, The Journal of Biological Chemistry.

Novel engineered HIV-1 East African Clade-A gp160 plasmid construct induces strong humoral and cell-mediated immune responses in vivo.

D. Weiner, S. Calarota, J. Boyer, 2003, Virology.

HIV-1 Nef-induced FasL induction and bystander killing requires p38 MAPK activation.

Crafford A. Harris, D. Green, D. Weiner, 2005, Blood.